Table 1

Baseline characteristics of the studied groups

Baseline characteristicsThrombectomy(n=10)Medical(n=22)p Value*
Age (years), mean±SD60±13.968.2±14.40.14
Gender (male)5 (50)15 (68)0.43
Hypertension6 (60)13 (59)1.00
Hyperlipidemia2 (20)5 (23)1.00
Atrial fibrillation3 (30)8 (36)1.00
Diabetes2 (20)4 (18)1.00
Smoking2 (20)2 (9)0.57
Anticoagulation0 (0)0 (0)
Arterial pressure (mm Hg), mean±SD100.3±20.5106.7±17.70.43
Baseline NIHSS score, median (IQR)4 (2–5)2 (1–4)0.09
Worst NIHSS score, mean±SD5.8±3.07.1±6.80.43
NIHSS score fluctuation >43 (30)9 (41)0.70
Wake-up stroke2 (20)7 (32)0.68
IV t-PA6 (60)2 (9)<0.01
NCCT ASPECTS, mean±SD8.5±1.09.1±0.80.14
CT perfusion (cc)
 Ischemic core, mean±SD8.5±9.90.4±1.30.06
 tMax>4 s, mean±SD132.1±111.9177.1±110.80.39
 tMax>6 s, mean±SD65.4±52.970.7±47.00.82
 tMax>10 s, mean±SD24.6±23.99.9±12.60.16
Times (hours), median (IQR)
 Last-known-normal to arrival6.25 (3.75–9.12)10.5 (4.3–15)0.19
 Arrival to deterioration5.2 (2.0–25.0)
 Deterioration to puncture1.5 (0.6–2.1)
 Deterioration to reperfusion2.7 (2.3–3.5)
Occlusion site0.62
 ACA1 (10)0 (0)
 MCA M16 (60)10 (45)
 MCA M21 (10)5 (23)
 Intracranial ICA0 (0)3 (14)
 Extracranial ICA0 (0)1 (5)
 Basilar2 (20)3 (14)
 Tandem0 (0)3 (14)0.53
Procedure10 (100)9 (41)
 Stentriever8 (80)8 (89)1.00
 mTICI 2b−310 (100)9 (100)1.00
 mTICI 35 (50)6 (67)0.65
Procedure length (min), mean±SD67.1±29.674.9±31.10.58
Etiology0.19
 Cardioembolic4 (40)8 (36)
 Large vessel atherosclerosis1 (10)7 (32)
 Intracranial atherosclerosis0 (0)2 (9)
 Other determined0 (0)1 (5)
 Cryptogenic5 (50)4 (18)
  • Results are shown as number (%) unless stated otherwise.

  • *Significant p values are shown in bold.

  • ACA, anterior communicating artery; ASPECTS, Alberta Stroke Program Early CT Score; ICA, internal carotid artery; NIHSS, National Institutes of Health Stroke Scale; MCA, middle cerebral artery; mTICI, modified Treatment in Cerebral Infarction; NCCT, non-contrast CT; t-PA, tissue plasminogen activator.